Mammary Gland Morphogenesis and Breast Cancer

乳腺形态发生与乳腺癌

基本信息

  • 批准号:
    8135217
  • 负责人:
  • 金额:
    $ 34.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-01 至 2015-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): More than 90% of breast cancers arise from epithelial cells or from progenitors with stem cell properties. Cell polarity is essential for stem cell asymmetric divisions, and failures in polarization can result in tumorigenesis. The Par polarity proteins are key regulators of asymmetric cell division. Par proteins also control polarization of differentiated epithelial cells. Yet the molecular mechanisms underlying polarity in mammary morphogenesis and the role of Par proteins in breast cancer remain largely unknown. We have developed methods that facilitate the study of mammary morphogenesis and tumorigenesis. To manipulate gene expression in mammary glands, stem cells are transduced with lentivirus, and mammary glands are regenerated in host mice from these cells. Lentiviral transduction enables rapid analysis of molecular mechanism through a knock-down/knock-in approach. Using these methods, an essential role for the Par3 polarity protein in mammary morphogenesis was discovered. In addition, silencing of Par3 potentiated tumor growth and metastasis. The goals are as follows: 1. How does Par3 regulate stem/progenitor self-renewal and differentiation during mammary gland morphogenesis? In the absence of Par3, atypical protein kinase C (aPKC) is mislocalized from the luminal apical surface. A knock-down/knock-in strategy will be used to ask if fate determination can be rescued by apically-tethered aPKC and by Par3 mutants. A novel miRNA sensor will be used to identify stem cells and to ask if Par3 is required for asymmetric division. Differential functions of Par3 in luminal and myoepithelial cells will be tested using new methods for cell-type specific RNAi silencing. 2. How does Par3 function to suppress tumor growth and metastasis? Preliminary data suggest that Par3 might limit mammary cell proliferation by suppressing Rac activity in the NICD cells, while separately controlling cell lineage determination and metastasis through aPKC. Lentivirus will be used to manipulate gene expression in primary cells, which are tested using the in vivo transplant model, tail vein injections, and in vitro mammosphere cultures. 3. Can we identify multiple additional metastasis suppressors/inducers by in vivo screening?. Mammary stem cells from ErbB2 mice will be infected with pooled lentiviruses that express a library of cDNAs, then implanted into cleared fat pads of wild type host mice. The viruses also express a red fluorescent protein. RFP-positive lung metastases will be isolated and screened by PCR to identify the cDNA associated with each metastatic colony. Positives will be prioritized based on expression patterns in human tumors for mechanistic studies. Together, these studies will provide insights into polarity protein signaling during stem/progenitor cell self-renewal and lineage determination, and identify new players in mammary tumor metastasis. PUBLIC HEALTH RELEVANCE: Breast cancer is one of the leading causes of death among women. Traditional approaches to studying the molecular basis for breast cancer, using genetically-engineered mice, are expensive and time-consuming; and studies in cell culture do not recapitulate the complex processes involved in building an organ or in tumor progression. New approaches are needed to address these issues. We have developed methods that facilitate the rapid analysis of gene function in mammary gland development and cancer. We will use these methods to identify new cancer genes, and to understand how breast cancers develop and metastasize.
描述(申请人提供):超过90%的乳腺癌来源于上皮细胞或具有干细胞特性的祖细胞。细胞的极性对干细胞的不对称分裂是必不可少的,极化失败可能导致肿瘤的发生。PAR极性蛋白是细胞不对称分裂的关键调节因子。PAR蛋白也控制分化上皮细胞的极化。然而,极性在乳腺形态发生中的潜在分子机制以及PAR蛋白在乳腺癌中的作用在很大程度上仍不清楚。我们已经开发出有助于研究乳腺形态发生和肿瘤发生的方法。为了控制乳腺中的基因表达,用慢病毒转导干细胞,然后在宿主小鼠身上从这些细胞再生乳腺。慢病毒转导可以通过敲击/敲入的方法快速分析分子机制。利用这些方法,发现了Par3极性蛋白在乳腺形态发生中的重要作用。此外,Par3的沉默增强了肿瘤的生长和转移。目的如下:1.在乳腺形态发生过程中,Par3如何调控干/祖细胞的自我更新和分化?在缺乏Par3的情况下,非典型蛋白激酶C(APKC)从管腔根尖表面错位。将使用敲击/敲入策略来询问是否可以通过顶部拴系的aPKC和Par3突变体来拯救命运决定。一种新型的miRNA传感器将被用来识别干细胞,并询问不对称分裂是否需要Par3。将使用新的细胞类型特异性RNAi沉默方法来测试Par3在腔上皮细胞和肌上皮细胞中的不同功能。2.Par3如何发挥抑制肿瘤生长和转移的作用?初步数据表明,Par3可能通过抑制NICD细胞中的Rac活性来限制乳腺细胞的增殖,同时通过aPKC单独控制细胞的谱系决定和转移。慢病毒将被用于操纵原代细胞中的基因表达,这些原代细胞通过体内移植模型、尾静脉注射和体外乳房培养进行测试。3.我们能否通过体内筛选确定多个额外的转移抑制/诱导因子?来自ErbB2小鼠的乳腺干细胞将被感染表达cDNA文库的慢病毒池,然后被植入野生型宿主小鼠的透明脂肪垫中。这些病毒还表达一种红色荧光蛋白。RFP阳性的肺转移瘤将被分离并通过聚合酶链式反应进行筛选,以确定与每个转移克隆相关的cDNAs。阳性将根据人类肿瘤的表达模式进行优先处理,以进行机制研究。总之,这些研究将为干细胞/祖细胞自我更新和谱系确定过程中的极性蛋白信号提供深入的见解,并确定在乳腺肿瘤转移中的新角色。 公共卫生相关性:乳腺癌是导致女性死亡的主要原因之一。使用转基因小鼠研究乳腺癌的分子基础的传统方法既昂贵又耗时;细胞培养研究也不能概括构建器官或肿瘤进展所涉及的复杂过程。需要新的方法来解决这些问题。我们已经开发出有助于快速分析乳腺发育和癌症中基因功能的方法。我们将使用这些方法来识别新的癌症基因,并了解乳腺癌是如何发展和转移的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

IAN G MACARA其他文献

IAN G MACARA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('IAN G MACARA', 18)}}的其他基金

Cancer and Context
癌症与背景
  • 批准号:
    10221624
  • 财政年份:
    2015
  • 资助金额:
    $ 34.75万
  • 项目类别:
Cancer and Context
癌症与背景
  • 批准号:
    8955798
  • 财政年份:
    2015
  • 资助金额:
    $ 34.75万
  • 项目类别:
Cancer and Context
癌症与背景
  • 批准号:
    9315574
  • 财政年份:
    2015
  • 资助金额:
    $ 34.75万
  • 项目类别:
Cancer and Context
癌症与背景
  • 批准号:
    9982211
  • 财政年份:
    2015
  • 资助金额:
    $ 34.75万
  • 项目类别:
Cancer and Context
癌症与背景
  • 批准号:
    9751082
  • 财政年份:
    2015
  • 资助金额:
    $ 34.75万
  • 项目类别:
Mammary Gland Morphogenesis and Breast Cancer
乳腺形态发生与乳腺癌
  • 批准号:
    8446157
  • 财政年份:
    2010
  • 资助金额:
    $ 34.75万
  • 项目类别:
Mammary Gland Morphogenesis and Breast Cancer
乳腺形态发生与乳腺癌
  • 批准号:
    8215927
  • 财政年份:
    2010
  • 资助金额:
    $ 34.75万
  • 项目类别:
Mammary Gland Morphogenesis and Breast Cancer
乳腺形态发生与乳腺癌
  • 批准号:
    8637935
  • 财政年份:
    2010
  • 资助金额:
    $ 34.75万
  • 项目类别:
Mammary Gland Morphogenesis and Breast Cancer
乳腺形态发生与乳腺癌
  • 批准号:
    7982626
  • 财政年份:
    2010
  • 资助金额:
    $ 34.75万
  • 项目类别:
MECHANISMS OF CELL POLARITY ESTABLISHMENT
细胞极性建立机制
  • 批准号:
    7932406
  • 财政年份:
    2009
  • 资助金额:
    $ 34.75万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 34.75万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 34.75万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 34.75万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 34.75万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 34.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 34.75万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 34.75万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 34.75万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 34.75万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 34.75万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了